| Reference |
|---|
Basu S, Mart xed nez Crist xf3 bal P, Frigol xe9 Vivas M, Pesarrodona M, Lewis M, Szulc E, et al. Rational optimization of a transcription factor activation domain inhibitor. Nat Struct Mol Biol. 2023;30:1958-1969 pubmed publisher |
Zhang S, Zeng L, Su B, Yang G, Wang J, Ming S, et al. The glycoprotein 5 of porcine reproductive and respiratory syndrome virus stimulates mitochondrial ROS to facilitate viral replication. MBio. 2023;14:e0265123 pubmed publisher |
Kwon H, Schafer J, Song N, Kaneko S, Li A, Xiao T, et al. Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer. Sci Immunol. 2022;7:eabq2630 pubmed publisher |
Mao F, Kong Y, Liu J, Rao X, Li C, Donahue K, et al. Diptoindonesin G antagonizes AR signaling and enhances the efficacy of antiandrogen therapy in prostate cancer. Prostate. 2022;82:917-932 pubmed publisher |
Zhang N, Bewick B, Schultz J, Tiwari A, Krencik R, Zhang A, et al. DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases. Neurotherapeutics. 2021;: pubmed publisher |
Schmidt K, Weidmann C, Hilimire T, Yee E, Hatfield B, Schneekloth J, et al. Targeting the Oncogenic Long Non-coding RNA SLNCR1 by Blocking Its Sequence-Specific Binding to the Androgen Receptor. Cell Rep. 2020;30:541-554.e5 pubmed publisher |
Kim K, Lee D, Park S, Jo S, Ku B, Park S, et al. Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera. Sci Rep. 2019;9:19654 pubmed publisher |
Grolez G, Gordiendko D, Clarisse M, Hammadi M, Desruelles E, Fromont G, et al. TRPM8-androgen receptor association within lipid rafts promotes prostate cancer cell migration. Cell Death Dis. 2019;10:652 pubmed publisher |
Kuo P, Tseng J, Chen H, Wu C, Omar H, Wang C, et al. Identification of SEPTIN12 as a novel target of the androgen and estrogen receptors in human testicular cells. Biochimie. 2019;158:1-9 pubmed publisher |
Bouchard J, Otero J, Scott D, Szulc E, Martin E, Sabri N, et al. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments. Mol Cell. 2018;72:19-36.e8 pubmed publisher |
Li D, Tian G, Wang J, Zhao L, Co O, Underill Z, et al. Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival. Prostate. 2018;78:1140-1156 pubmed publisher |
Chopra H, Khan Z, Contreras J, Wang H, Sedrak A, Zhu Y. Activation of p53 and destabilization of androgen receptor by combinatorial inhibition of MDM2 and MDMX in prostate cancer cells. Oncotarget. 2018;9:6270-6281 pubmed publisher |
De Mol E, Szulc E, Di Sanza C, Martínez Cristóbal P, Bertoncini C, Fenwick R, et al. Regulation of Androgen Receptor Activity by Transient Interactions of Its Transactivation Domain with General Transcription Regulators. Structure. 2018;26:145-152.e3 pubmed publisher |
Kato Y, Ochiai K, Kawakami S, Nakao N, Azakami D, Bonkobara M, et al. Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines. BMC Vet Res. 2017;13:170 pubmed publisher |
Sreenath T, Macalindong S, Mikhalkevich N, Sharad S, Mohamed A, Young D, et al. ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development. Sci Rep. 2017;7:1109 pubmed publisher |
Chattopadhyay I, Wang J, Qin M, Gao L, Holtz R, Vessella R, et al. Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures. Oncotarget. 2017;8:10324-10347 pubmed publisher |
Read J, Ingram A, Al Saleh H, Platko K, Gabriel K, Kapoor A, et al. Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles. Eur J Cancer. 2017;70:62-74 pubmed publisher |
Corso Díaz X, de Leeuw C, Alonso V, Melchers D, Wong B, Houtman R, et al. Co-activator candidate interactions for orphan nuclear receptor NR2E1. BMC Genomics. 2016;17:832 pubmed |
Yamaguchi A, Takanashi K. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription. Sci Rep. 2016;6:35195 pubmed publisher |
Patsch K, Chiu C, Engeln M, Agus D, Mallick P, Mumenthaler S, et al. Single cell dynamic phenotyping. Sci Rep. 2016;6:34785 pubmed publisher |
Schmidt K, Joyce C, Buquicchio F, Brown A, Ritz J, Distel R, et al. The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region. Cell Rep. 2016;15:2025-37 pubmed publisher |
Chiu C, Patsch K, Cutrale F, Soundararajan A, Agus D, Fraser S, et al. Intracellular kinetics of the androgen receptor shown by multimodal Image Correlation Spectroscopy (mICS). Sci Rep. 2016;6:22435 pubmed publisher |
Ochiai K, Morimatsu M, Kato Y, Ishiguro Oonuma T, Udagawa C, Rungsuriyawiboon O, et al. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity. Oncotarget. 2016;7:3283-96 pubmed publisher |
Doberstein K, Milde Langosch K, Bretz N, Schirmer U, Harari A, Witzel I, et al. L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor. BMC Cancer. 2014;14:958 pubmed publisher |
Golovine K, Makhov P, Teper E, Kutikov A, Canter D, Uzzo R, et al. Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. Prostate. 2013;73:23-30 pubmed publisher |
Stenoien D, Cummings C, Adams H, Mancini M, Patel K, DeMartino G, et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum Mol Genet. 1999;8:731-41 pubmed |
